Nexalin Technology (NXL) Other Accumulated Expenses (2021)
Nexalin Technology (NXL) posted quarterly Other Accumulated Expenses of $42843.0 for Q4 2021.
Nexalin Technology (NXL) Other Accumulated Expenses (2021) Analysis & Trends
Nexalin Technology's Other Accumulated Expenses history runs 1 years deep, the most recent figure standing at $42843.0 for Q4 2021.
- In Q4 2021, Other Accumulated Expenses changed N/A year-over-year to $42843.0; the TTM figure through Dec 2021 stood at $42843.0 (changed N/A YoY), while the FY2021 annual figure was $42843.0, changed N/A from the prior year.
- Other Accumulated Expenses for Q4 2021 stood at $42843.0.
- The five-year high for Other Accumulated Expenses was $42843.0 in Q4 2021, with the low at $42843.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Nexalin Technology | 7.04 Mn | 6.03 Mn | 8,897.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 42,843.00 |